U.S. Body Composition Analyzers Market Size & Share Analysis - Trends, Drivers, Competitive Landscape, and Forecasts (2024 - 2030)

Chapter 1. Research Scope

1.1. Research Objectives

1.2. Market Definition

1.3. Analysis Period

1.4. Market Size Breakdown by Segments

1.4.1. Market size breakdown, by product

1.4.2. Market size breakdown, by mobility

1.4.3. Market size breakdown, by application

1.4.4. Market size breakdown, by region

1.5. Market Data Reporting Unit

1.5.1. Value

1.6. Key Stakeholders

Chapter 2. Research Methodology

2.1. Secondary Research

2.1.1. Paid

2.1.2. Unpaid

2.1.3. P&S Intelligence database

2.2. Primary Research

2.3. Market Size Estimation

2.4. Data Triangulation

2.5. Currency Conversion Rates

2.6. Assumptions for the Study

2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Market Indicators

Chapter 5. Industry Outlook

5.1. Market Dynamics

5.1.1. Trends

5.1.2. Drivers

5.1.3. Restraints/challenges

5.1.4. Impact analysis of drivers/restraints

5.2. Impact of COVID-19

5.3. Porter’s Five Forces Analysis

5.3.1. Bargaining power of buyers

5.3.2. Bargaining power of suppliers

5.3.3. Threat of new entrants

5.3.4. Intensity of rivalry

5.3.5. Threat of substitutes

Chapter 6. Global Market

6.1. Overview

6.2. Market Revenue, by Product (2019–2030)

6.3. Market Revenue, by Mobility (2019–2030)

6.4. Market Revenue, by Application (2019–2030)

6.5. Market Revenue, by Region (2019–2030)

Chapter 7. Competitive Landscape

7.1. List of Market Players and their Offerings

7.2. Competitive Benchmarking of Key Players

7.3. Product Benchmarking of Key Players

7.4. Recent Strategic Developments

Chapter 8. Company Profiles

8.1. CONMED Corporation

8.1.1. Business overview

8.1.2. Product and service offerings

8.1.3. Key financial summary

8.2. Cardinal Health Inc.

8.2.1. Business overview

8.2.2. Product and service offerings

8.2.3. Key financial summary

8.3. Medline Industries Inc.

8.3.1. Business overview

8.3.2. Product and service offerings

8.3.3. Key financial summary

8.4. Hologic Inc.

8.4.1. Business overview

8.4.2. Product and service offerings

8.4.3. Key financial summary

8.5. Tanita Corporation

8.5.1. Business overview

8.5.2. Product and service offerings

8.5.3. Key financial summary

8.6. Omron Corporation

8.6.1. Business overview

8.6.2. Product and service offerings

8.6.3. Key financial summary

8.7. InBody Co. Ltd.

8.7.1. Business overview

8.7.2. Product and service offerings

8.7.3. Key financial summary

8.8. Seca GmbH & Co. KG

8.8.1. Business overview

8.8.2. Product and service offerings

8.8.3. Key financial summary

8.9. RJL Systems Inc.

8.9.1. Business overview

8.9.2. Product and service offerings

8.9.3. Key financial summary

Chapter 9. Appendix

9.1. Abbreviations

9.2. Sources and References

9.3. Related Reports